Status | Study |
Recruiting |
Study Name: Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years Condition: Acanthamoeba Keratitis Date: 2016-04-12 Interventions: Other: no intervention |
Recruiting |
Study Name: Auranofin Trial for GI Protozoa Condition: Amoebic Dysentery Giardiasis Date: 2016-04-07 Interventions: Drug: Auranofin Auranofin is a |
Completed |
Study Name: Field Studies of Amebiasis in Bangladesh Condition: Amebiasis Cryptosporidium Date: 2016-03-22 |
Active, not recruiting |
Study Name: Ameparomo Capsules 250 mg Drug Use Investigation Condition: Intestinal Amebiasis Date: 2016-02-09 |
Completed |
Study Name: Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects Condition: Acanthamoeba Keratitis Date: 2015-07-20 Interventions: Drug: 0.04% PHMB 0.04% PHMB ey |
Completed |
Study Name: Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population Condition: Helminthiasis Amoebiasis Date: 2015-03-05 Interventions: Drug: Mebendazole Mebendazole |
Completed |
Study Name: Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders Condition: Soil-transmitted Helminthiasis Schistosomiasis Strongyloid Date: 2014-03-21 Interventions: Procedure: Stool culturing for pathogenic bacteria |
Completed |
Study Name: Auranofin PK Following Oral Dose Administration Condition: Amoebiasis Date: 2014-03-13 Interventions: Drug: Auranofin Auranofin is a gold-containing chemical salt available as 3mg capsules. Cohort 1 receive |
Completed |
Study Name: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) Condition: Visceral Leishmaniasis Human African Trypanosomiasis Enter Date: 2013-01-09 Interventions: Device: rk28 ICT rk28 ICT is a |
Active, not recruiting |
Study Name: Is it Effective to Treat Patients With Blastocystis Hominis Infection? Condition: Blastocystis Hominis Infections Date: 2012-01-25 Interventions: Drug: Metronidazole 3x500 mg/d |